| Bempegaldesleukin | BMS-986321; ONO-7911; NKTR-214 | Phase 3 Clinical | Nektar Therapeutics | Brain Neoplasms; Carcinoma, Renal Cell; Coronavirus Disease 2019 (COVID-19); Ependymoma; Glioma; Head and Neck Neoplasms; Leukemia; Lymphoma; Medulloblastoma; Melanoma; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Prostatic Neoplasms, Castration-Resistant; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Urinary Bladder Neoplasms | 詳細 |
| AWT-020 | AWT020; AWT-020; JS213; JS-213 | Phase 2 Clinical | Anwita Biosciences Inc | Autoimmune Diseases of the Nervous System; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Lung Neoplasms; Melanoma; Neoplasms; Solid tumours | 詳細 |
| GI-101 | SIM-323; SIM323; SIM0323; GI-101 | Phase 2 Clinical | GI Innovation Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Neoplasms; Solid tumours; Uterine Cervical Neoplasms | 詳細 |
| MB-501 | MB501; MB-501 | Phase 2 Clinical | Ascendis Pharma Inc | | 詳細 |
| Pegenzileukin | IBI-127; THOR-707; SAR-444245 | Phase 2 Clinical | Synthorx Inc | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Hodgkin Disease; Intestinal Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma; Mesothelioma; Multiple Myeloma; Neoplasm Metastasis; Oropharyngeal Neoplasms; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms | 詳細 |
| IPH-6501 | IPH-6501; IPH-65 | Phase 2 Clinical | Innate Pharma SA | Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms | 詳細 |
| LTC-004 | LTC004; LTC-004 | Phase 2 Clinical | Leto Laboratories Co Ltd | Colorectal Neoplasms; Neoplasms; Pancreatic Neoplasms; Sarcoma; Solid tumours | 詳細 |
| FB-102 | FB-102; FB102 | Phase 2 Clinical | Forte Biosciences Inc | Alopecia Areata; Celiac Disease; Graft vs Host Disease; Malabsorption Syndromes; Vitiligo | 詳細 |
| TransCon IL-2 β/γ | | Phase 2 Clinical | Ascendis Pharma A/S | Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Ovarian Neoplasms; Solid tumours | 詳細 |
| MDNA-11 | MDNA-11; MDNA11 | Phase 2 Clinical | Medicenna Therapeutics Corp | Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Melanoma; Mesothelioma; Microsatellite Instability; Microsatellite instability-high cancer; Mismatch Repair Deficient Cancer; Ovarian Neoplasms; Peritoneal Neoplasms; Skin Melanoma; Skin Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 詳細 |
| Simlukafusp alfa | FAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FP | Phase 1 Clinical | F. Hoffmann-La Roche Ltd | Breast Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Head and Neck Neoplasms; Melanoma; Solid tumours; Uterine Cervical Neoplasms | 詳細 |
| BJ-001(Boji Biomedical Technology) | BJ-001 | Phase 1 Clinical | Boji Biomedical Technology (Hangzhou) Co Ltd | Communicable Diseases; Neoplasm Metastasis; Solid tumours | 詳細 |
| STK-009 | STK-009 | Phase 1 Clinical | Synthekine Inc | Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Scleroderma, Systemic | 詳細 |
| NL-201 (Neoleukin Therapeutics) | NL-201 | Phase 1 Clinical | Neoleukin Therapeutics Inc | | 詳細 |
| Recombinant human interleukin 15(Beijing Kawin) | | Phase 1 Clinical | Beijing Kawin Technology Share-Holding Co Ltd | | 詳細 |